J&J, Lilly & Merck Reassure Investors About Medicare Reform Process
Executive Summary
The lessons from the health care reform debate in the mid-1990s will ensure a more "sensible" debate over health care in 2000, J&J CEO Ralph Larsen told analysts during a Jan. 25 conference call.
You may also be interested in...
Clinton Emphasizes Biomedical Research Over Rx Cost In State Of The Union
President Clinton's State of the Union message emphasized the value of biomedical research rather than the cost of drugs.
Propulsid Physician Education On Cardiac Risk To Be Presented To Committee
Janssen will detail professional education campaign plans for conveying cardiac risks associated with the nighttime heartburn treatment Propulsid (cisapride) at the April 12 FDA advisory committee review of the product's safety.
Clinton Emphasizes Biomedical Research Over Rx Cost In State Of The Union
President Clinton's State of the Union message emphasized the value of biomedical research rather than the cost of drugs.